Mind Medicine (MindMed) (MNMD) Competitors

Tilray (NASDAQ:TLRY) and Mind Medicine (MindMed) (NASDAQ:MNMD) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, community ranking, valuation, profitability, dividends, media sentiment, risk and earnings.

Which has more risk & volatility, TLRY or MNMD?

Tilray has a beta of 2.14, meaning that its share price is 114% more volatile than the S&P 500. Comparatively, Mind Medicine (MindMed) has a beta of 2.48, meaning that its share price is 148% more volatile than the S&P 500.

Does the media favor TLRY or MNMD?

In the previous week, Tilray had 6 more articles in the media than Mind Medicine (MindMed). MarketBeat recorded 16 mentions for Tilray and 10 mentions for Mind Medicine (MindMed). Mind Medicine (MindMed)'s average media sentiment score of 0.70 beat Tilray's score of 0.32 indicating that Mind Medicine (MindMed) is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tilray	3 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Mind Medicine (MindMed)	3 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders believe in TLRY or MNMD?

9.4% of Tilray shares are owned by institutional investors. Comparatively, 27.9% of Mind Medicine (MindMed) shares are owned by institutional investors. 0.9% of Tilray shares are owned by company insiders. Comparatively, 2.3% of Mind Medicine (MindMed) shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has stronger valuation & earnings, TLRY or MNMD?

Mind Medicine (MindMed) has lower revenue, but higher earnings than Tilray. Tilray is trading at a lower price-to-earnings ratio than Mind Medicine (MindMed), indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray	$788.94M	1.55	-$244.98M	-$0.27	-5.00
Mind Medicine (MindMed)	N/A	N/A	-$95.73M	-$2.26	-3.43

Is TLRY or MNMD more profitable?

Mind Medicine (MindMed) has a net margin of 0.00% compared to Tilray's net margin of -26.79%. Tilray's return on equity of -2.00% beat Mind Medicine (MindMed)'s return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray	-26.79%	-2.00%	-1.60%
Mind Medicine (MindMed)	N/A	-47.56%	-35.55%

Do analysts recommend TLRY or MNMD?

Tilray presently has a consensus target price of $2.63, suggesting a potential upside of 94.44%. Mind Medicine (MindMed) has a consensus target price of $25.38, suggesting a potential upside of 227.00%. Given Mind Medicine (MindMed)'s stronger consensus rating and higher possible upside, analysts clearly believe Mind Medicine (MindMed) is more favorable than Tilray.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
Mind Medicine (MindMed)	0 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	3.25

Does the MarketBeat Community favor TLRY or MNMD?

Tilray received 398 more outperform votes than Mind Medicine (MindMed) when rated by MarketBeat users. However, 92.45% of users gave Mind Medicine (MindMed) an outperform vote while only 59.21% of users gave Tilray an outperform vote.

Company	Underperform	Outperform
Tilray	Outperform Votes 447 59.21%	Underperform Votes 308 40.79%
Mind Medicine (MindMed)	Outperform Votes 49 92.45%	Underperform Votes 4 7.55%

Summary

Mind Medicine (MindMed) beats Tilray on 12 of the 18 factors compared between the two stocks.